- Home
- MSB vs ABSI Comparison
MSB vs ABSI Comparison
Compare MSB & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSB | ABSI |
|---|---|---|
| Founded | 1961 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.0M | 357.9M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MSB | ABSI |
|---|---|---|
| Price | $31.98 | $2.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.98 |
| AVG Volume (30 Days) | 42.6K | ★ 2.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.08% | N/A |
| EPS Growth | ★ 391.29 | 21.67 |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $98,595,651.00 | $4,534,000.00 |
| Revenue This Year | N/A | $10.72 |
| Revenue Next Year | N/A | $313.07 |
| P/E Ratio | $36.94 | ★ N/A |
| Revenue Growth | ★ 331.26 | N/A |
| 52 Week Low | $22.55 | $2.01 |
| 52 Week High | $42.38 | $5.23 |
Technical Indicators
Market Signals| Indicator | MSB | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 36.45 |
| Support Level | $28.62 | N/A |
| Resistance Level | $32.94 | $2.88 |
| Average True Range (ATR) | 2.03 | 0.16 |
| MACD | 0.19 | -0.01 |
| Stochastic Oscillator | 64.08 | 7.26 |
Price Performance
Historical ComparisonAbout MSB Mesabi Trust
Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.